SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stephen A. Feig, TEMPORARY REMOVAL: Overdiagnosis of Breast Cancer at Screening is Clinically Insignificant, Academic Radiology, 2015,

    CrossRef

  2. 2
    Jong-Myon Bae, Jeonghee Lim, 과진단: 역학적 개념과 산출법, Epidemiology and Health, 2015, e2015004

    CrossRef

  3. 3
    Per-Henrik Zahl, Adjusting the incidence increase when screening for statistical lead time will always give estimates of overdiagnosis close to zero, Breast Cancer Research, 2014, 16, 3, 404

    CrossRef

  4. 4
    Robert A. Smith, Author’s Reply, Journal of the American College of Radiology, 2014, 11, 11, 1098

    CrossRef

  5. 5
    Maj Rabjerg, Minne Nedergaard Mikkelsen, Steen Walter, Niels Marcussen, Incidental renal neoplasms: is there a need for routine screening? A Danish single-center epidemiological study, APMIS, 2014, 122, 8
  6. 6
    Maria Sala, Laia Domingo, Montserrat Rué, Mercè Comas, Isabel Torá-Rocamora, Francesc Macià, Xavier Castells, Investigación en cribado de cáncer de mama: camino hacia estrategias personalizadas y decisiones compartidas, Revista de Senología y Patología Mamaria, 2014, 27, 4, 176

    CrossRef

  7. 7
    Stephen A. Feig, Overdiagnosis of Invasive Breast Cancer and DCIS: Why Do Estimates Vary?, Breast Diseases: A Year Book Quarterly, 2014, 25, 3, 196

    CrossRef

  8. 8
    Peer Christiansen, Ilse Vejborg, Niels Kroman, Iben Holten, Jens Peter Garne, Peter Vedsted, Susanne Møller, Elsebeth Lynge, Position paper: Breast cancer screening, diagnosis, and treatment in Denmark, Acta Oncologica, 2014, 53, 4, 433

    CrossRef

  9. 9
    Stephen A. Feig, Screening Mammography Benefit Controversies, Radiologic Clinics of North America, 2014, 52, 3, 455

    CrossRef

  10. 10
    Marcia C. Javitt, Section Editor's Notebook: Breast Cancer Screening and Overdiagnosis Unmasked, American Journal of Roentgenology, 2014, 202, 2, 259

    CrossRef

  11. 11
    K. Hellerhoff, Grenzen des Mammographiescreenings, Der Radiologe, 2013, 53, 9, 764

    CrossRef

  12. 12
    Ragnhild Sørum Falk, Solveig Hofvind, Per Skaane, Tor Haldorsen, Overdiagnosis among women attending a population-based mammography screening program, International Journal of Cancer, 2013, 133, 3
  13. 13
    Stephen W Duffy, Dharmishta Parmar, Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time, Breast Cancer Research, 2013, 15, 3, R41

    CrossRef

  14. 14
    S Taghipour, D Banjevic, A B Miller, N Montgomery, A K S Jardine, B J Harvey, Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study, British Journal of Cancer, 2013, 108, 3, 542

    CrossRef

  15. 15
    I. D. Nagtegaal, S. W. Duffy, Reduction in rate of node metastases with breast screening: consistency of association with tumor size, Breast Cancer Research and Treatment, 2013, 137, 3, 653

    CrossRef

  16. 16
    Stephen A. Feig, Reply, American Journal of Roentgenology, 2013, 200, 1, W98

    CrossRef

  17. 17
    M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox, The benefits and harms of breast cancer screening: an independent review, British Journal of Cancer, 2013, 108, 11, 2205

    CrossRef

  18. You have free access to this content18
    W. Phil Evans, Breast cancer screening: Successes and challenges, CA: A Cancer Journal for Clinicians, 2012, 62, 1
  19. 19
    Necdet B Gunsoy, Montserrat Garcia-Closas, Sue M Moss, Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom, Breast Cancer Research, 2012, 14, 6, R152

    CrossRef

  20. 20
    Peter C. Gøtzsche, Karsten Juhl Jørgensen, Per-Henrik Zahl, Jan Mæhlen, Why mammography screening has not lived up to expectations from the randomised trials, Cancer Causes & Control, 2012, 23, 1, 15

    CrossRef

  21. 21
    Bradford R. Hirsch, Gary H. Lyman, Breast Cancer Screening with Mammography, Current Oncology Reports, 2011, 13, 1, 63

    CrossRef

  22. 22
    R. de Gelder, E. A. M. Heijnsdijk, N. T. van Ravesteyn, J. Fracheboud, G. Draisma, H. J. de Koning, Interpreting Overdiagnosis Estimates in Population-based Mammography Screening, Epidemiologic Reviews, 2011, 33, 1, 111

    CrossRef

  23. 23
    Daniel B. Kopans, Robert A. Smith, Stephen W. Duffy, Mammographic Screening and “Overdiagnosis”, Radiology, 2011, 260, 3, 616

    CrossRef

  24. 24
    Donella Puliti, Guido Miccinesi, Eugenio Paci, Overdiagnosis in breast cancer: Design and methods of estimation in observational studies, Preventive Medicine, 2011, 53, 3, 131

    CrossRef

  25. 25
    Iris D. Nagtegaal, Prue C. Allgood, Stephen W. Duffy, Olive Kearins, E. O. Sullivan, Nancy Tappenden, Matthew Wallis, Gill Lawrence, Prognosis and pathology of screen-detected carcinomas, Cancer, 2011, 117, 7
  26. 26
    Nora Pashayan, Paul Pharoah, László Tabár, David E. Neal, Richard M. Martin, Jenny Donovan, Freddie Hamdy, Stephen W. Duffy, Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence, Cancer Epidemiology, 2011, 35, 2, 139

    CrossRef

  27. 27
    Stephen A. Feig, Stephen W. Duffy, Breast Imaging, 2011,

    CrossRef

  28. 28
    Gill Lawrence, Matthew Wallis, Prue Allgood, Iris D. Nagtegaal, Jane Warwick, Fay H. Cafferty, Nehmat Houssami, Olive Kearins, Nancy Tappenden, Emma O’Sullivan, Stephen W. Duffy, Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias, Breast Cancer Research and Treatment, 2009, 116, 1, 179

    CrossRef

  29. 29
    S W Duffy, E Lynge, H Jonsson, Reply: Estimation of lead-time and overdiagnosis in breast cancer screening, British Journal of Cancer, 2009, 100, 1, 220

    CrossRef

  30. 30
    Jeffrey A. Tice, Karla Kerlikowske, Screening and Prevention of Breast Cancer in Primary Care, Primary Care: Clinics in Office Practice, 2009, 36, 3, 533

    CrossRef

  31. 31
    S W Duffy, E Lynge, H Jonsson, S Ayyaz, A H Olsen, Complexities in the estimation of overdiagnosis in breast cancer screening, British Journal of Cancer, 2008, 99, 7, 1176

    CrossRef

  32. 32
    S. W. Duffy, I. D. Nagtegaal, M. Wallis, F. H. Cafferty, N. Houssami, J. Warwick, P. C. Allgood, O. Kearins, N. Tappenden, E. O'Sullivan, G. Lawrence, Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival, American Journal of Epidemiology, 2008, 168, 1, 98

    CrossRef

  33. 33
    K. Koch, C. Weymayr, Kritik der Krebsfrüherkennung, Der Onkologe, 2008, 14, 2, 181

    CrossRef

  34. 34
    Corné Biesheuvel, Alexandra Barratt, Kirsten Howard, Nehmat Houssami, Les Irwig, Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review, The Lancet Oncology, 2007, 8, 12, 1129

    CrossRef

  35. 35
    Weinstein Galit, Manfred S. Green, Keinan-Boker Lital, Routine screening mammography in women older than 74 years: A review of the available data, Maturitas, 2007, 57, 2, 109

    CrossRef

  36. 36
    Solveig Hofvind, Berta Geller, Pamela M. Vacek, Steinar Thoresen, Per Skaane, Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program, European Journal of Epidemiology, 2007, 22, 7, 447

    CrossRef